Gerard Scimeca – Chairman, CASE June 18, 2019 Establishing free and fair trade agreements between the United States and […]
Gerard Scimeca – Chairman, CASE June 14, 2019 The potential of a forced breakup of Facebook, Amazon and other […]
Gerard Scimeca – Chairman, CASE June 13, 2019 As President Trump’s trade talks with our major partners sway back […]
Gerard Scimeca – Chairman, CASE June 12, 2019 From Sacramento to Congress, there is an aggressive push afoot across the country […]
Matthew Kandrach – President, CASE June 11, 2019 With America’s reliance on imported minerals rising rapidly, the last thing we […]
June 5, 2019 CASE today praised the Trump administration and Department of the Interior Secretary David Bernhardt for the release […]
Matthew Kandrach – President, CASE June 3, 2019 – https://bit.ly/2KoGoEr A recent study published in Health Affairs reached a controversial conclusion, that […]
Gerard Scimeca – Chairman, CASE May 28, 2019 – https://bit.ly/2ED1ZFI The proposed merger between Sprint and T-Mobile has for months been […]
Gerard Scimeca – Chairman, CASE May 24, 2019 It has long been an irony of the sugar industry that a […]
May 20, 2019 Great news for consumers and for our nation overall came this morning from the announcement by FCC […]
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/